CF Pharma
CF Pharma, officially known as CF Pharma Limited, is a leading player in the pharmaceutical industry, headquartered in Ireland (IE). Established in 2010, the company has rapidly expanded its operations across Europe and beyond, focusing on the development and distribution of high-quality generic medicines and specialty pharmaceuticals. With a commitment to innovation, CF Pharma offers a diverse portfolio of products, including injectable and oral formulations that cater to various therapeutic areas. Their unique approach to quality assurance and regulatory compliance sets them apart in a competitive market. Recognised for their dedication to excellence, CF Pharma has achieved significant milestones, positioning itself as a trusted partner in healthcare. The company continues to enhance its market presence through strategic collaborations and a robust pipeline of new products, solidifying its reputation as a reliable source of pharmaceutical solutions.
DitchCarbon Score
How does CF Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CF Pharma's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CF Pharma's reported carbon emissions
CF Pharma, headquartered in Ireland (IE), currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed information, it is essential to monitor CF Pharma's future disclosures regarding their climate commitments and any potential strategies they may implement to reduce their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CF Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
